Myocardial protection part 2 Flashcards

1
Q

heart takes up oxygen over time so blood cardioplegia must

A

be delivered over time not a volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Four Main Objectives of Cardioplegia

A
  • Immediate/sustained electromechanical arrest
  • Rapid/sustained homogenous myocardial cooling
  • Maintenance of therapeutic additives in effective concentrations
  • Periodic washout of metabolic inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Two Main Goals of Cardioplegia

A

Prevent myocardial ischemic damage
(induction/maintenance)
Prevent/minimize injury
(reperfusion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

limit these detrimental changes to heart

A

rapid cellular conversion from aerobic (O2) to anaerobic metabolism (no O2)
• high-energy phosphate (e.g. ATP) depletion • intracellular acidosis • calcium influx • cell membrane disruption
• Intracellular Ca+2 accumulation • Cellular edema (inability to consume oxygen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Cardioplegia Setups (types)

A
Crystalloid
• Single pass system
Blood
• Fixed ratio • Bridged
• Non-bridged • Variable/controlled ratio
MPS
• Microplegia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

3 Phases of Cardioplegia

A

I. Induction of arrest II. Maintenance of arrest III. Reperfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cold Induction Solutions: Crystalloid and Blood

A

ECF cardioplegia solution Potassium depolarization arrest
• Depolarizes the cardiac myocyte with hyperkalemia
• Ca2+ATPase and Na+/K+ATPase still operative and need energy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pure Crystalloid Cardioplegia Induction Advantages

A

• History of use • Ease • Cheap, low viscosity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Pure Crystalloid Cardioplegia Induction pitfalls

A
  • Cellular edema •Low O2 capacity • Left shift oxy-Hgb curve •Activates platelets, leukocytes, and complement
  • Impaired membrane stabilization• Hemodilution
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Lactated Ringer’s 1000 mL electrolyte concentration

A

KCL 20 mEq MgCl 32 mEq Mannitol 12.5 g NaHCO2 6.5 mEq. Add prior to use Procaine 10% 2.7 mL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Normosol 1000 mL concentrations

A

NaHCO2 35 mEq KCL 35 mEq Mannitol 25% 12.5 g

Add prior to use Lidocaine 75 mg Ntg 500 mcg Albumin 25% 12.5 g

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Cold Blood Cardioplegia Induction Advantages

A

O2 carrying capacity Reduced hemodilution Buffering/oncotic effects O2 radical scavengers present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Cold Blood Cardioplegia Induction pitfalls

A

Sludging Oxy-Hgb curve disruption •Possible red cell damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Warm Blood Cardioplegia Induction Advantages

A
  • Improved aerobic metabolism
  • Improved LV function
  • Improves compromised hearts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Warm Blood Cardioplegia Induction pitfalls

A

•Expensive due to additives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Example: Warm Induction Solution (8:1)

A

• D50 11ml • D5 27ml• CPD 67ml• THAM •83ml Aspartate/Glutamate •62ml KCL 2meq/L 60mEq •Lidocaine 100mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Low Potassium Maintenance

A

Usually every 15 to 20 minutes Cold blood cardioplegia or crystalloid Restores arrest post wash-out

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Preparation for Reperfusion

A

• Substrate-enhanced warm cardioplegia • Limit calcium • Limit PO2 •Controlled reperfusion
The endothelium is damaged during ischemia,
damage can increase through unregulated reperfusion
Upon XC MAP → 40 mmHg for 1-2 minutes. Removal: MAP → 70 mmHg after 2 minutes.
• De-air adequately • Avoid ventricular distension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

The “Hot Shot” (when?)

A

Just prior to removal of the aortic cross clamp

In addition to cross clamp drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Whats in the hot shot

A

• Aspartate Glutamate • Tham • Dextrose • CPD

Due to cost – warm blood may be substituted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Typical Warm Reperfusion Solution

A
  • THAM (0.3 M) solution – 225 mL • CPD–225mL • Dextrose 50% - 40 mL • MSA/MSG 0.46 M – 250 mL
  • Dextrose 5% - 200 mL • KCl (2 mEq/L) – 15 mL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
Custodial Cardioplegia (HTK)
Histidine-Tryptophan-Ketoglutarate
A
  • Intracellular cardioplegia solution • Low sodium concentration
  • Histidine • Tryptophan • Mannitol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Benefits of HTK Cardioplegia

A
  • Initial use: organ preservation • Now used in cardiac surgery
  • Longer safe time of ischemia • During valve surgery • Minimally invasive procedures
24
Q

Del Nido Solution (4:1)

A

Plasmalyte base which is similar to ECF: • 140 mEq/L sodium • 5m Eq/L potasium • 3 mEq/L magnesium
• 98 mEq/L chloride • 27 mEq/L acetate • 23 mEq/L gluconate

25
del nido solution additives
Mannitol 20% MgSO4 50% NaHCO2 8.4% KCL 2 mEq/L Lidocaine 1 % | 16.3 mL 4 mL 13 mL 13 mL 13 mL
26
additional solutions
• Plegisol ,Baxter Cardioplegia, St. Thomas Solution, University of Wisconsin Solution
27
Warm Continuous Retrograde Blood Cardioplegia | • Lichtenstein (1991) suggested that the heart could be maintained at
37oC throughout the cross clamp period to enhance perioperative myocardial function.
28
Warm Continuous Retrograde Blood Cardioplegia Normothermic patients experienced a lower incidence
of post-operative low output syndrome with no differences in mortality or myocardial infarction.
29
Warm retrograde cardioplegia flow must be
>100 mL/min to minimize myocardial lactate production
30
Single Clamp Technique
One clamp episode One unclamp episode Distals and proximals done during one ischemic time • Used with calcified stiff aortas
31
Side Biting Clamp Technique
Two clamp episodes Two unclamping episodes Distals done during first ischemic time Proximals done during second ischemic time • Ischemic time is only with fully clamped aorta • Shorter clamp times
32
Intermittent Crossclamp
* Increased risk of stroke • Not commonly used | * Clamp time is the sum of all fully ischemic times
33
Fibrillatory Arrest Creates a nearly motionless heart by placing an
alternating current generator in contact with the left ventricle.
34
fib arrest Left side of heart can be opened without the fear
of ejecting air into the aorta.
35
fib arrest should be used in conjunction with
hypothermia
36
Fibrillatory Arrest Advantages:
• Avoid cross clamp • Quiescent heart with coronary perfusion
37
fib arrest Disadvantages:
•Higher energy requirement than arrested heart • Spontaneous ejection will result in air emboli Keep MAP elevated
38
Additional Strategies to Enhance Protection
• Anesthetic agents (↑ preconditioning) • Acute normovolemic hemodilution (↓ A fib) • Neutrophil depletion (↓ V fib) • Erythropoietin (↓ myocardial injury) • N-acetylcysteine (↓ oxidative stress) • Deferoxamine (↓lipid peroxidation) • Statins (↑NO release)
39
Monitoring Effectiveness for the Perfusionist GOAL:
optimize uniformity and effectiveness of delivery (especially retrograde) • Temperature • pH •Electrical Activity
40
Monitoring - Temperature Thermo coupled needle usually inserted
septal muscle (myocardial temp probe)
41
monitoring temp. Ensure delivery of
adequate dose (is it going where it belongs?)
42
monitoring temp. See efficacy of delivery
• Antegrade - cases of aortic insufficiency • Retrograde - cannula position ( in RA?)
43
Determine when next dose needed use
timers
44
reasons for failure to arrest
• Aortic insufficiency • Cross-clamp or cardioplegia needle malpositioned. • Inadequate solution (low potassium) • Low flow? • Low pressure? • Temperature?
45
Myocardial Protection for Off-Pump Procedures
Regional ischemia unavoidable • May become global problem when multiple vessels grafted Use of suction-based stabilizers has reduced the problem of working on a moving target • Provide good exposure without excess compression of ventricle Ischemic preconditioning • Brief period of vessel occlusion before occluding for construction of the anastomosis
46
Myocardial Protection: Off-Pump Procedures cont.
Myocardial Protection: Off-Pump Procedures • Keep normal to high systemic blood pressure • May increase flow through collaterals vessels • Attach proximal end of graft before attaching distal • Immediate re-establishment of flow to ischemic area • Use of intracoronary shunt • Perfusion-assisted direct coronary artery bypass (PADCAB) • Perfuse completed grafts
47
K ACTION
electromechanical arrest
48
Na action
↓ edema/intracelluar Ca++ buildup
49
Ca++ action
Membrane stabilization
50
NaHCO3 action
↑ pH
51
THAM action
↑ pH
52
glucose action
Substrate, ↑ Osmolarity, ↓ edema
53
Mannitol
↑ Osmolarity
54
high potassium solution concentrations
KCl 100mmol/L. THAM 12mmol/L. MgSO4 9 mmol/L Dextrose 250 mmol/L CPD 20ML
55
low potassium solution concentrations
KCL 40 mmol/L THAM 12 mmol/L MgSO4 9 mmol/L | Dextrose 250 mmol/l CPD 20 mL